Facebook tracking pixel
S10.AI
ICD-10-CM · F03.92GeneralSystemic

Dementia with Psychosis

Understanding Dementia with Psychosis: This resource provides information on diagnosing and documenting dementia-related psychosis, including clinical features, diagnostic criteria, and medical coding for psychotic symptoms in dementia. Learn about best practices for healthcare professionals and improve your clinical documentation accuracy.

Also known as
Dementia-related PsychosisPsychotic Symptoms in Dementia
Definition

Cognitive decline with hallucinations, delusions, or paranoia.

Clinical signs

Memory loss, confusion, agitation, personality changes, and abnormal beliefs or perceptions.

Common settings

Nursing homes, assisted living facilities, memory care units, and home healthcare.

Related Codes

ICD-10 Code Families

Complete code families applicable to F03.92

F02.81
Dementia with behavioral disturbance
F00-F09
Organic, including symptomatic, mental disorders
F20-F29
Schizophrenia, schizotypal and delusional disorders
Code Comparison

When to use each related code

DescriptionWhen to use
Dementia with psychosis features.Use when dementia is present with hallucinations, delusions, or other psychotic symptoms.
Dementia without psychosis.Use when cognitive decline impacts daily life but psychosis is absent. Consider subtypes like Alzheimer's.
Primary psychotic disorder.Use when psychosis is the primary feature, and dementia is absent or secondary. e.g., Schizophrenia.
Documentation

Best-practice checklist

  • Document dementia type (e.g., Alzheimer's, Lewy body).
  • Specify psychosis onset relative to dementia diagnosis.
  • Describe psychotic symptoms (hallucinations, delusions).
  • Document impact on function and behavior.
  • Assess and document medication history and response.
Coding & Audit Risks

Common pitfalls to avoid

Unspecified Dementia Type

Coding dementia without specifying the type (e.g., Alzheimer's, vascular) can lead to inaccurate reimbursement and quality reporting.

Psychosis Severity

Insufficient documentation of psychosis severity (e.g., frequency, duration, impact on function) may impact medical necessity reviews.

Causality Documentation

Lack of clear documentation linking psychosis directly to dementia may cause coding and billing errors or compliance issues.

Mitigation

Best-practice tips

  • 01Document psychosis onset, duration, & severity for accurate ICD-10 coding (F02.81, G31.84).
  • 02Assess and document contributing factors like infections, medications, and metabolic imbalances.
  • 03Differentiate delirium from dementia-related psychosis for appropriate care plan and coding.
  • 04Use standardized scales (BPRS, NPI) to quantify psychotic symptoms for improved tracking and communication.
  • 05Implement non-pharmacological interventions (e.g., calming environment) before considering antipsychotics.
Clinical Decision Support

Step-by-step checklist

  1. 1

    Document cognitive impairment: MoCA, MMSE, SLUMS

  2. 2

    Specify psychosis features: hallucinations, delusions

  3. 3

    Rule out delirium, other psychiatric disorders

  4. 4

    Assess for contributing medications, infections

  5. 5

    Consider safety: wandering, aggression risk

Documentation Template

Ready-to-paste narrative

Patient presents with clinical features consistent with Dementia with Psychosis (also known as Dementia-related Psychosis or Psychotic Symptoms in Dementia).  The patient's cognitive decline, documented through neurocognitive testing and functional assessment, meets the criteria for dementia.  In addition to cognitive impairment, the patient exhibits psychotic symptoms including hallucinations (visual, auditory, or other), delusions (paranoid, grandiose, or other), andor disorganized thought processes.  Onset and progression of psychosis were evaluated in relation to the dementia diagnosis to rule out primary psychotic disorders.  Differential diagnosis considered other conditions that can mimic dementia with psychosis, such as delirium, medication side effects, and other psychiatric disorders.  The patient's medical history, family history, and current medication list were reviewed.  The impact of these psychotic symptoms on the patient's function, safety, and caregiver burden was assessed.  Treatment plan includes consideration of non-pharmacological interventions such as behavioral management strategies and caregiver education, as well as pharmacological management with antipsychotic medications, considering potential risks and benefits in this population.  Ongoing monitoring of cognitive function, psychotic symptoms, and treatment response will be essential.  ICD-10 coding will be based on the specific dementia etiology and the presence of psychosis.  Medical billing will reflect the complexity of the patient's presentation and the services provided.  Further investigation and specialist consultation may be warranted.
FAQs

Common questions and answers

How can I differentiate between dementia-related psychosis and primary psychotic disorders in older adults presenting with hallucinations and delusions?+

Differentiating between dementia-related psychosis and primary psychotic disorders like schizophrenia in older adults can be challenging due to overlapping symptoms. Focus on a thorough clinical history, including cognitive assessment, onset and progression of symptoms, and functional decline. In dementia-related psychosis, cognitive impairment typically precedes or coincides with the onset of psychotic symptoms like hallucinations and delusions. Primary psychotic disorders, however, usually manifest with psychosis as the primary and prominent feature, with cognitive decline occurring later if at all. Consider using validated cognitive screening tools like the Montreal Cognitive Assessment (MoCA) or Mini-Mental State Examination (MMSE) to assess cognitive function. Explore how neuroimaging and biomarker assessments can further aid in the differential diagnosis and consider implementing a comprehensive assessment strategy incorporating collateral information from family members or caregivers. This can provide valuable insights into the patient's behavioral changes and symptom timeline.

What are the best evidence-based non-pharmacological interventions for managing agitation and aggression in patients with dementia with psychosis?+

Non-pharmacological interventions are often the first line of treatment for managing agitation and aggression in dementia with psychosis patients. Prioritize creating a calm and structured environment, minimizing sensory overload, and ensuring a consistent daily routine. Behavioral interventions such as redirection, validation therapy, and reminiscence therapy can be effective in de-escalating agitated behaviors. Consider implementing caregiver education programs to equip families with strategies for communication and behavioral management techniques. Learn more about personalized activities tailored to the patient's interests and abilities that can provide meaningful engagement and reduce boredom and frustration, common triggers for agitation. Explore the benefits of music therapy, aromatherapy, and other sensory-based interventions to promote relaxation and reduce anxiety. A multidisciplinary approach involving occupational therapy, social work, and nursing staff can provide comprehensive support and enhance the effectiveness of non-pharmacological interventions.

What are the recommended antipsychotic medications and dosing strategies for treating psychosis in dementia, considering the potential risks and benefits in this vulnerable population?+

Antipsychotic medication use in dementia with psychosis requires careful consideration of the potential benefits and risks, including cerebrovascular events, mortality, and extrapyramidal symptoms. Start low and go slow is the recommended dosing strategy, titrating the medication gradually to minimize adverse effects. Second-generation antipsychotics like risperidone, olanzapine, and quetiapine are often preferred due to their lower risk of extrapyramidal side effects compared to first-generation antipsychotics. However, even these medications carry risks, and their use should be reserved for cases where non-pharmacological interventions have proven insufficient and the patient's safety or the safety of others is at risk. Regular monitoring of the patient's response to medication, including assessment of psychotic symptoms, cognitive function, and adverse effects, is crucial. Consider implementing a shared decision-making approach involving the patient, family, and healthcare team to discuss the risks and benefits of antipsychotic medication and explore alternative treatment options. Learn more about the latest guidelines and recommendations for the appropriate use of antipsychotics in dementia with psychosis to ensure optimal patient care.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.